MIRA Pharmaceuticals
MIRA
NASDAQ
Biotech
Markets openAuto-updating · last checked
Preclinical pharma developing oral therapies for neuropathic pain and anxiety.
12-month trend
Fundamentals
Revenue, earnings and balance-sheet data for MIRA, updated as each quarter is reported.
Recent news
No PSA coverage mentioning MIRA Pharmaceuticals yet.